Please assess the completion status of the following clinical trial:

Trial Title: COMO: Cognition Study With HIV+ Patients (CTNPT 015)

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* are 18 years and older~* have the capacity to give informed consent as determined by the research nurse~* have unexplained cognitive decline (reported either by the patient or an outside informant)~* have been on a stable ART regimen for \> 6 months~* have an undetectable viral load in plasma for at least 6 months (a single blip of ≤ 150 copies/mL will be accepted)~* have not had a change in medications that could potentially interfere with cognition in the past 4 months~Exclusion Criteria:~* detectable VL in the plasma~* past history of dementia~* past history of Central Nervous System opportunistic infection or stroke~* current substance abuse ( as per DSM-IV criteria) other than cigarettes~* coagulopathy~* thrombocytopenia~* use of Coumadin~* intra-cranial hypertension

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Change in ARVs to improve cognition (Type: EXPERIMENTAL): Change in ARVs to improve cognition: Personalized change in antiretrovirals will be based on CSF analysis

Based on this trial design, predict the completion outcome and termination type (if applicable).